ECU
BSX icon

Eisler Capital (UK)’s Boston Scientific BSX Stock Holding History

Eisler Capital (UK)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.1M Sell
156,315
-42,364
-21% -$3.34M 0.06% 241
2024
Q2 		$15.3M Buy
198,679
+84,182
+74% +$6.16M 0.1% 196
2024
Q1 		$7.84M Buy
114,497
+7,497
+7% +$482K 0.07% 246
2023
Q4 		$6.19M Buy
+107,000
New +$5.71M 0.05% 275
2022
Q2 		– Sell
-250,000
Closed -$11.1M – 415
2022
Q1 		$11.1M Buy
+250,000
New +$10.8M 0.19% 129
2021
Q2 		– Sell
-150,000
Closed -$5.8M – 202
2021
Q1 		$5.8M Buy
+150,000
New +$5.68M 0.5% 50

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Eisler Capital (UK)'s BSX Position: Q2 2024 in Review

Eisler Capital (UK) sold out of Boston Scientific (BSX) in Q2 2024, closing a stake of 3,728 shares — an estimated $273K sold.

Eisler Capital (UK) first reported a position in BSX in Q1 2021 and held it in 4 quarters. The position peaked at $1.35M in Q4 2023. 1,317 funds tracked by Wall St. Rank hold BSX as of Q2 2024.

  • Eisler Capital (UK) reported no remaining Boston Scientific position as of Q2 2024 after selling out during the quarter.
  • Eisler Capital (UK) sold 3,728 Boston Scientific shares in Q2 2024, an estimated $273K.
  • Eisler Capital (UK) first reported a position in Boston Scientific in Q1 2021 and held it in 4 quarters.
  • Eisler Capital (UK)'s Boston Scientific position peaked at $1.35M in Q4 2023.
  • 1,317 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2024.

Based on Eisler Capital (UK)'s 13F filing for Q2 2024, filed 13 Aug 2024.